India- Orthobiologics Market Overview 2019 Size, Market Dynamics, Segments, Global Players, Future Trends, Key Trends, Types, Application and Forecast to 2023


(MENAFN- GetNews) The Exhaustive Study for Global Orthobiologics Market Research Report is added on Market Research Future. To provide detail analysis of the market structure along with forecast, about various segments and sub-segments of the Orthobiologics. It is also cover country level analysis of the market with respect to the current market size and future growth prospect.

Some of the key players in the global orthobiologics market are Arthrex, Inc., Exactech, Inc., Globus Medical Inc., Integra LifeSciences, Johnson & Johnson, Medline Industries, Inc., NuVasive, Inc., Stryker Corporation, Wright Medical Group N.V., Zimmer Biomet, and Others

Request Free Sample Copy at https://www.marketresearchfuture.com/sample_request/7826

Orthobiologics Market overview:

Orthobiologics are derived from the human body and used by surgeons for treating injuries. It helps in easy recovery and healing of wounds. It can be useful for treating broken bones and injured muscles, tendons, and ligaments. The surge in cases of trauma and sports injury, rising demand for biologics in minimally invasive procedures, increasing product approvals, and raising awareness are expected to drive the growth of the global Orthobiologics market during the forecast period.

Moreover, emerging technological inventions in biomaterials, growing obese and geriatric population, and increasing research and development activities by top players such as mergers, expansion, and collaboration for the development of new products and launches by major players are also boosting the growth of the market. According to the report published by the Centers for Disease Control and Prevention (CDC), in 2016, 5.1% of men of 65 years and over are suffering from the lumbar spine in the US. Also, 24.5% of women 65 years of age and over have a lumbar spine in US.

The high costs associated with the orthobiologics, absence of proper reimbursement policies and scarcity of skilled workforce may hamper the growth of the market during the assessment period.

Segmentations

The global orthobiologics market has been segmented on the basis of product, application, end-user, and region.

Based on product, the market has been classified as a Demineralized bone matrix (DBM), Bone morphogenetic protein (BPM), Allograft, Viscosupplementation products, Synthetic bone substitutes, and Others.

Global orthobiologics market on the basis of application has been segmented into Osteoarthritis & degenerative arthritis, Spinal fusion, Fracture recovery, Soft tissue injuries, and Others.

Based on end-user, the market has been segmented into Hospitals, Orthopedic Clinics, and Others.

Regional Analysis:

The market is likely to dominate by Americas during the forecast period owing to the well-established healthcare infrastructure, rising incidences of spinal disorders, obese and geriatric population, and preference for minimally invasive procedures.

Europe is expected to be the second-largest market in the global orthobiologics market due to the rising adoption of newly introduced treatment procedures and technologies by a physician and patient awareness, government funding and support of the healthcare sector.

The Asia-Pacific market is likely to hold a significant market share in the orthobiologics market. The rising demand for advanced treatment, awareness and increasing investment in healthcare are responsible for the growth of this market in the region.

The market in the Middle East & Africa is expected to account for the smallest share of the global orthobiologics market due to an underdeveloped healthcare sector, lack of technical knowledge, and poor medical facilities.

TOC:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1. Definition

2.2. Scope Of The Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3. Limitations

Chapter 3. Research Methodology

3.1. Introduction

3.2. Primary Research

3.3. Secondary Research

3.4. Market Size Estimation

Chapter 4. Market Dynamics

Continued…

LIST OF TABLES:

Table 1. Global Orthobiologics Market Synopsis, 20192024

Table 2. Global Orthobiologics Market Estimates And Forecast, 20192024 (USD Million)

Table 3. Global Orthobiologics Market, By Region, 20192024 (USD Million)

Table 4. Global Orthobiologics Market, By Product, 20192024 (USD Million)

Table 5. Global Orthobiologics Market, By Application, 20192024 (USD Million)

Table 6. Global Orthobiologics Market, By End User, 20192024 (USD Million)

Table 7. North America: Orthobiologics Market, By Product, 20192024 (USD Million)

Table 8. North America: Orthobiologics Market, By Application, 20192024 (USD Million)

Table 9. North America: Orthobiologics Market, By End User, 20192024 (USD Million)

Table 10. US: Orthobiologics Market, By Product, 20192024 (USD Million)

Continued…

Browse Full Report at https://www.marketresearchfuture.com/reports/orthobiologics-market-7826

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Media Contact
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address: Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar
City: Pune
State: Maharashtra
Country: India
Website: https://www.marketresearchfuture.com/reports/orthobiologics-market-7826


MENAFN0709201900703268ID1098974715


GetNews

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.